TREA

98040253 - EVOMYO

Follow

Information

  • Trademark
  • 98040253
  • Serial Number
    98040253
  • Filing Date
    June 13, 2023
    a year ago
  • Transaction Date
    January 13, 2025
    a month ago
  • Status Date
    January 13, 2025
    a month ago
  • Published for Opposition Date
    May 21, 2024
    9 months ago
  • Location Date
    July 16, 2024
    7 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CHANG, BETTY
  • Attorney Name
    Maury M. Tepper, III
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EVOMYO
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Case File Event Statements
  • 6/16/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/17/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/31/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/6/2024 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2024 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/6/2024 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/16/2024 - 10 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/17/2024 - 10 months ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/16/2024 - 10 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/16/2024 - 10 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/1/2024 - 10 months ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/21/2024 - 9 months ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/21/2024 - 9 months ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/16/2024 - 7 months ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/13/2025 - a month ago
    15 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/13/2025 - a month ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/13/2025 - a month ago
    17 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/13/2025 - a month ago
    16 - SOU EXTENSION 1 FILED Type: EXT1